RGEN,HOLX,AZTA Stock Price and Quote

Dollar change -2.29
Percentage change -1.81	%

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VXF VBK MDY IBB FBT SPMD IWR

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	5.46%	Shs Outstand	56.25M	Perf Week	11.59%
Market Cap	7.00B	Forward P/E	56.65	EPS next Y	2.19	Insider Trans	-1.64%	Shs Float	53.19M	Perf Month	0.25%
Enterprise Value	6.97B	PEG	-	EPS next Q	0.42	Inst Own	103.27%	Short Float	6.84%	Perf Quarter	0.88%
Income	-13.83M	P/S	10.38	EPS this Y	6.43%	Inst Trans	1.76%	Short Ratio	4.36	Perf Half Y	-14.93%
Sales	673.96M	P/B	3.39	EPS next Y	30.53%	ROA	-0.48%	Short Interest	3.64M	Perf YTD	-13.61%
Book/sh	36.65	P/C	9.87	EPS next 5Y	22.13%	ROE	-0.68%	52W High	182.52 -31.87%	Perf Year	-24.43%
Cash/sh	12.60	P/FCF	66.03	EPS past 3/5Y	- -	ROIC	-0.51%	52W Low	102.96 20.76%	Perf 3Y	-51.47%
Dividend Est.	-	EV/EBITDA	50.16	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.16%	Volatility	4.31% 4.15%	Perf 5Y	-15.88%
Dividend TTM	-	EV/Sales	10.35	EPS Y/Y TTM	-245.82%	Oper. Margin	4.10%	ATR (14)	4.91	Perf 10Y	240.95%
Dividend Ex-Date	-	Quick Ratio	7.32	Sales Y/Y TTM	8.73%	Profit Margin	-2.05%	RSI (14)	54.96	Recom	1.59
Dividend Gr. 3/5Y	- -	Current Ratio	8.59	EPS Q/Q	159.98%	SMA20	4.74%	Beta	1.07	Target Price	180.53
Payout	-	Debt/Eq	0.33	Sales Q/Q	14.81%	SMA50	1.34%	Rel Volume	0.69	Prev Close	126.64
Employees	1778	LT Debt/Eq	0.32	Earnings	Jul 29 BMO	SMA200	-10.03%	Avg Volume	833.91K	Price	124.35
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.69% 4.10%	Trades		Volume	574,823	Change	-1.81%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-22-25	Resumed	Stephens	Overweight	$160
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168

Show Previous Ratings

Aug-12-25 12:53AM	RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty (StockStory) +8.51%
12:35AM	5 Must-Read Analyst Questions From Repligen's Q2 Earnings Call (StockStory)
Aug-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-31-25 07:30AM	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (GlobeNewswire)
Jul-29-25 11:52PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:26PM	Loading…
02:26PM	Why Repligen (RGEN) Stock Is Up Today (StockStory)
08:45AM	Repligen (RGEN) Lags Q2 Earnings Estimates (Zacks)
08:09AM	Repligen's (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
07:41AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Jul-28-25 09:22AM	Repligen Corp (RGEN) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-27-25 11:06PM	Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-22-25 09:40AM	Netflix downgraded, Intel initiated: Wall Street's top analyst calls (The Fly)
Jul-21-25 09:45AM	Here's Why Repligen (RGEN) is a Strong Growth Stock (Zacks)
Jul-18-25 03:11PM	Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know (StockStory) -6.28%
12:03AM	Loading…
12:03AM	3 Reasons RGEN is Risky and 1 Stock to Buy Instead (StockStory)
Jul-17-25 07:30AM	Repligen to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
04:19PM	Loading…
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)
Mar-11-25 05:01AM	A Look Back at Drug Development Inputs & Services Stocks Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack (StockStory) +7.40%
Mar-10-25 08:06PM	Analyst Report: Repligen Corporation (Morningstar Research) -12.02%
Mar-06-25 08:02AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Feb-21-25 04:28PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:06AM	Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:24AM	Q4 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 07:21PM	Analyst Report: Repligen Corporation (Morningstar Research) +7.92%
02:00PM	Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook (Benzinga)
08:54AM	What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings (GuruFocus.com)
08:45AM	Repligen (RGEN) Beats Q4 Earnings Estimates (Zacks)
08:08AM	Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates (StockStory)
07:50AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:05AM	Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow (StockStory)
Feb-12-25 08:44PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-11-25 07:30AM	Repligen to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-29-25 03:19AM	Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? (Zacks)
Jan-13-25 07:18PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-07-25 07:30AM	Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-06-25 07:30AM	Repligen Launches the CTech SoloVPE PLUS System (GlobeNewswire)
Dec-20-24 09:21AM	Repligen Corporation (RGEN) Fell Along with Peers (Insider Monkey)
Dec-18-24 09:40PM	Analyst Report: Repligen Corporation (Morningstar Research) -6.83%
Dec-16-24 07:43PM	Analyst Report: Repligen Corporation (Morningstar Research)
08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Dec-12-24 11:30AM	Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:30AM	Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report (GlobeNewswire)
Dec-09-24 09:03AM	Several Factors Lifted Repligen Corporation (RGEN) in Q3 (Insider Monkey)
07:30AM	Repligen Launches Novel AVIPure dsRNA Resin in OPUS Pre-packed Columns (GlobeNewswire)
Nov-13-24 09:54AM	Analyst Report: Repligen Corporation (Morningstar Research)
02:37AM	Q3 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-24 11:55AM	Repligen Stock Soars 10% on Record Growth and Bold Moves (GuruFocus.com) +6.51%
09:05AM	Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:04AM	Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 07:30AM	Repligen to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Madaus Martin D	Director	Aug 08 '25	Buy	112.13	1,800	201,830	1,800	Aug 12 12:47 PM
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM
Hunt Anthony	Director	Dec 05 '24	Option Exercise	33.87	11,808	399,937	151,648	Dec 05 08:26 PM
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM
Hunt Anthony	Director	Sep 10 '24	Option Exercise	33.87	10,000	338,700	162,031	Sep 12 11:35 AM
Hunt Anthony	Director	Sep 10 '24	Sale	145.37	22,191	3,225,927	139,840	Sep 12 11:35 AM
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM

Dollar change -0.25
Percentage change -0.37	%

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR SPY IVV RSP XLV SPLV IHI

Index	S&P 500	P/E	28.13	EPS (ttm)	2.41	Insider Own	0.86%	Shs Outstand	222.22M	Perf Week	-0.37%
Market Cap	15.08B	Forward P/E	15.02	EPS next Y	4.51	Insider Trans	0.29%	Shs Float	220.51M	Perf Month	5.92%
Enterprise Value	15.73B	PEG	4.13	EPS next Q	1.10	Inst Own	104.60%	Short Float	2.00%	Perf Quarter	21.65%
Income	557.10M	P/S	3.73	EPS this Y	3.89%	Inst Trans	2.45%	Short Ratio	1.70	Perf Half Y	6.59%
Sales	4.04B	P/B	3.11	EPS next Y	6.49%	ROA	6.30%	Short Interest	4.41M	Perf YTD	-5.94%
Book/sh	21.79	P/C	8.03	EPS next 5Y	6.82%	ROE	11.38%	52W High	84.39 -19.65%	Perf Year	-16.85%
Cash/sh	8.45	P/FCF	16.18	EPS past 3/5Y	-22.74% -	ROIC	7.57%	52W Low	51.90 30.66%	Perf 3Y	-6.13%
Dividend Est.	-	EV/EBITDA	12.61	Sales past 3/5Y	-10.56% 3.66%	Gross Margin	55.93%	Volatility	1.55% 1.89%	Perf 5Y	2.90%
Dividend TTM	-	EV/Sales	3.89	EPS Y/Y TTM	-17.73%	Oper. Margin	23.58%	ATR (14)	1.26	Perf 10Y	66.45%
Dividend Ex-Date	-	Quick Ratio	2.81	Sales Y/Y TTM	1.28%	Profit Margin	13.79%	RSI (14)	57.68	Recom	2.42
Dividend Gr. 3/5Y	- -	Current Ratio	3.55	EPS Q/Q	5.09%	SMA20	1.38%	Beta	0.57	Target Price	73.53
Payout	0.00%	Debt/Eq	0.52	Sales Q/Q	1.23%	SMA50	3.41%	Rel Volume	1.66	Prev Close	68.06
Employees	7063	LT Debt/Eq	0.52	Earnings	Jul 30 AMC	SMA200	1.67%	Avg Volume	2.59M	Price	67.81
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.52% 1.32%	Trades		Volume	4,291,829	Change	-0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75
Jul-18-22	Downgrade	BTIG Research	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$75
Apr-04-22	Downgrade	Evercore ISI	Outperform → In-line	$80

Show Previous Ratings

Aug-15-25 09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
Aug-14-25 02:41AM	What Are Wall Street Analysts' Target Price for Hologic Stock? (Barchart)
Aug-13-25 08:25AM	Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength (Zacks)
Aug-12-25 11:55PM	Hologic's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
11:53PM	HOLX Q2 Deep Dive: Breast Health Turnaround and New Product Launches Drive Momentum (StockStory)
04:49AM	Loading…
04:49AM	STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories (GlobeNewswire)
Aug-11-25 07:30AM	[Latest] Global Digital Mammography Market Size/Share Worth USD 5.32 Billion by 2034 at a 11.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-08-25 08:43AM	Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? (Zacks)
Aug-06-25 07:38AM	Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? (Zacks)
Aug-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:04AM	Tempus AI Targets Breast Cancer With Expanded Next - AI Platform (Zacks)
Aug-04-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	Interpreting Hologic (HOLX) International Revenue Trends (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Aug-01-25 08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
07:59AM	Loading…
Jul-31-25 07:59AM	Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down (Zacks)
05:10AM	Analyst Report: Hologic, Inc. (Morningstar Research)
03:31AM	Hologic Inc (HOLX) Q3 2025 Earnings Call Highlights: Surpassing Expectations Amidst Challenges (GuruFocus.com)
Jul-30-25 05:30PM	Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics (Zacks)
05:10PM	Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:08PM	Hologic: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:06PM	Hologic's (NASDAQ:HOLX) Q2 Sales Beat Estimates, Stock Soars (StockStory)
04:01PM	Hologic Announces Financial Results for Third Quarter of Fiscal 2025 (Business Wire)
Jul-29-25 08:05AM	Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver? (Zacks)
04:02AM	Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche (GlobeNewswire)
Jul-28-25 11:18PM	Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-25-25 09:22AM	Mammography Equipment Market Analysis and Forecast Report 2025: Hologic, Siemens, GE Lead Competitive Dynamics in Mammography Industry (GlobeNewswire)
09:15AM	Seeking Clues to Hologic (HOLX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:38AM	HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now? (Zacks)
Jul-24-25 09:06AM	Hologic's International Momentum Takes Shape: Will Execution Pay Off? (Zacks)
04:30AM	Loading…
Jul-23-25 04:30AM	[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT) (GlobeNewswire)
Jul-22-25 05:45PM	Hologic (HOLX) Laps the Stock Market: Here's Why (Zacks)
08:32AM	Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report? (Zacks)
Jul-16-25 08:55AM	Hologic Rides on AI-Powered Breast Health Innovations: What's Next? (Zacks)
Jul-15-25 05:45PM	Why Hologic (HOLX) Dipped More Than Broader Market Today (Zacks)
12:08PM	What to Expect From Hologic's Q3 2025 Earnings Report (Barchart)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-14-25 04:11PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Jul-11-25 04:07AM	Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer (GlobeNewswire)
Jul-10-25 08:25AM	Hologic's GYN Surgical Dominance: What's Powering the Road Ahead? (Zacks)
Jul-09-25 05:45PM	Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jul-08-25 08:31AM	Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? (Zacks)
Jul-04-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jul-02-25 04:05PM	Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 (Business Wire)
09:35AM	Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern (Zacks)
Jun-26-25 05:45PM	Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
04:08AM	5 Revealing Analyst Questions From Hologic's Q1 Earnings Call (StockStory)
Jun-25-25 09:13AM	How Hologic Leverages Its Financial Firepower to Drive Long-Term Value (Zacks)
Jun-23-25 09:32AM	HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now? (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-20-25 06:41AM	How Is Hologics Stock Performance Compared to Other Health Care Equipment Stocks? (Barchart)
Jun-17-25 05:45PM	Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Jun-16-25 08:30AM	Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence? (Zacks)
Jun-11-25 08:29AM	Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate? (Zacks)
Jun-10-25 08:04PM	Analyst Report: Hologic, Inc. (Morningstar Research)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Jun-09-25 08:42AM	Hologic Climbs 13% in a Month: How Should You Play the Stock? (Zacks)
Jun-04-25 08:41AM	Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact? (Zacks)
May-30-25 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
May-28-25 05:16PM	S&P 500 Gains and Losses Today: FICO Shares Regain Ground After Recent Slump (Investopedia)
04:29AM	Why Hologic, Inc. (HOLX) Went Up On Tuesday (Insider Monkey)
May-27-25 11:35PM	Q1 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory) +14.54%
05:22PM	S&P 500 Gains and Losses Today: Index Rises After Trump Extends EU Tariff Deadline (Investopedia)
04:07PM	Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. (Barrons.com)
02:04PM	Why Is Hologic (HOLX) Stock Rocketing Higher Today (StockStory)
08:24AM	HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? (Zacks)
May-22-25 05:05PM	Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index Test in Helping to Deliver More Personalized Care to Patients (Business Wire)
May-21-25 12:01AM	3 Reasons to Sell HOLX and 1 Stock to Buy Instead (StockStory)
May-19-25 09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
May-15-25 04:46PM	HOLX Q1 Earnings Call: Tariffs, Market Headwinds, and Portfolio Diversification Shape 2025 Outlook (StockStory)
May-13-25 04:10PM	Hologic to Webcast Presentations at Upcoming Investor Conferences (Business Wire)
09:16AM	Understanding Hologic (HOLX) Reliance on International Revenue (Zacks)
May-12-25 08:44AM	Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? (Zacks)
May-07-25 12:16PM	S&P 500's five most overbought and oversold stocks (Seeking Alpha)
May-06-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
12:32AM	1 of Wall Street's Favorite Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
May-02-25 02:25PM	Analyst Report: Hologic, Inc. (Morningstar Research) -5.45%
11:57AM	Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More (Investopedia)
10:11AM	Q2 2025 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
07:25AM	Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down (Zacks)
03:15AM	Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth (GuruFocus.com)
May-01-25 08:24PM	Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:10PM	Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:17PM	Hologic: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Second Quarter of Fiscal 2025 (Business Wire)
Apr-30-25 05:50PM	Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
09:31AM	Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss? (Zacks)
Apr-28-25 09:15AM	Insights Into Hologic (HOLX) Q2: Wall Street Projections for Key Metrics (Zacks)
08:45AM	GYN Surgical Division Likely to Drive Hologic's Q2 Earnings (Zacks)
Apr-25-25 08:18AM	Hologic Set to Report Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Apr-24-25 08:10AM	Groundbreaking New Data on Hologics AI-Powered Mammography Technology to Be Presented at SBI (Business Wire)
Apr-23-25 09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-22-25 10:10AM	Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside? (Zacks)
09:03AM	3 Cash-Producing Stocks Walking a Fine Line (StockStory)
08:08AM	Hologic Details Environmental, Social and Governance Efforts Including Expanded Environmental Ambitions in New Sustainability Report (Business Wire)
Apr-21-25 05:45PM	Hologic (HOLX) Stock Moves -1.08%: What You Should Know (Zacks)
Apr-14-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
Apr-11-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-10-25 05:14AM	Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Option Exercise	62.60	22,902	1,433,659	52,813	Dec 06 04:28 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Sale	76.34	24,856	1,897,482	27,957	Dec 06 04:28 PM
Mitchell Essex D	Officer	Dec 04 '24	Proposed Sale	76.34	24,856	1,897,484		Dec 04 12:24 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Option Exercise	40.95	32,805	1,343,214	136,721	Sep 03 04:15 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Sale	80.56	52,679	4,243,662	84,042	Sep 03 04:15 PM
Oberton Karleen Marie	Officer	Aug 29 '24	Proposed Sale	80.56	52,679	4,243,657		Aug 29 04:36 PM

Dollar change -0.20
Percentage change -0.65	%

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI IWM VB VXF VBR ROBO SPSM IWN DFAT

Index	RUT	P/E	-	EPS (ttm)	-2.43	Insider Own	2.12%	Shs Outstand	45.78M	Perf Week	4.68%
Market Cap	1.39B	Forward P/E	39.03	EPS next Y	0.78	Insider Trans	0.26%	Shs Float	44.87M	Perf Month	-5.36%
Enterprise Value	1.12B	PEG	-	EPS next Q	0.19	Inst Own	115.78%	Short Float	9.92%	Perf Quarter	13.78%
Income	-111.59M	P/S	2.30	EPS this Y	22.87%	Inst Trans	5.95%	Short Ratio	5.20	Perf Half Y	-32.62%
Sales	604.93M	P/B	0.83	EPS next Y	54.56%	ROA	-1.47%	Short Interest	4.45M	Perf YTD	-39.22%
Book/sh	36.55	P/C	4.34	EPS next 5Y	34.75%	ROE	-1.74%	52W High	55.63 -45.38%	Perf Year	-44.04%
Cash/sh	7.01	P/FCF	30.50	EPS past 3/5Y	- -	ROIC	-6.46%	52W Low	23.91 27.10%	Perf 3Y	-50.90%
Dividend Est.	-	EV/EBITDA	26.72	Sales past 3/5Y	8.51% -3.41%	Gross Margin	43.11%	Volatility	5.78% 5.69%	Perf 5Y	-45.08%
Dividend TTM	-	EV/Sales	1.86	EPS Y/Y TTM	13.50%	Oper. Margin	-4.08%	ATR (14)	1.80	Perf 10Y	170.61%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.44	Sales Y/Y TTM	-8.15%	Profit Margin	-18.45%	RSI (14)	47.79	Recom	2.88
Dividend Gr. 3/5Y	- -	Current Ratio	2.76	EPS Q/Q	-828.00%	SMA20	-3.48%	Beta	1.65	Target Price	31.43
Payout	-	Debt/Eq	0.03	Sales Q/Q	-16.70%	SMA50	-2.79%	Rel Volume	0.66	Prev Close	30.59
Employees	3300	LT Debt/Eq	0.03	Earnings	Aug 05 BMO	SMA200	-20.26%	Avg Volume	856.10K	Price	30.39
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	39.40% -3.64%	Trades		Volume	566,615	Change	-0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	Raymond James	Mkt Perform → Outperform	$35
Jul-22-25	Resumed	Stephens	Equal-Weight	$35
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Show Previous Ratings

Aug-13-25 05:50PM	Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know (StockStory) +9.83%
12:13AM	The Top 5 Analyst Questions From Azenta's Q2 Earnings Call (StockStory)
12:11AM	AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter (StockStory)
Aug-07-25 03:36PM	Why Azenta (AZTA) Stock Is Up Today (StockStory)
Aug-06-25 02:50PM	Azenta (AZTA) Stock Trades Up, Here Is Why (StockStory) +5.58%
12:40PM	Loading…
Aug-05-25 12:40PM	Why Azenta (AZTA) Stock Is Trading Lower Today (StockStory) -17.00%
07:16AM	Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets (StockStory)
06:30AM	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
Aug-03-25 11:10PM	Azenta (AZTA) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 04:05PM	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
08:30AM	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
Jul-30-25 04:05PM	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-23-25 04:05PM	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-25 02:06PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +5.11%
Jul-17-25 11:31PM	Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
11:33PM	Loading…
Jul-16-25 11:33PM	Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Loading…
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-01-24 04:15PM	Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report (PR Newswire)
04:05PM	Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-12-24 08:00AM	Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum (PR Newswire)
Feb-08-24 10:53AM	Azenta, Inc. (NASDAQ:AZTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 05:02PM	Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 (GuruFocus.com)
04:05PM	Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 (PR Newswire)
Feb-02-24 08:00AM	Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management (PR Newswire)
Jan-25-24 04:05PM	Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-11-24 04:05PM	Azenta to Host Investor Day on March 14, 2024 (PR Newswire)
Jan-09-24 04:05PM	Azenta to Participate in the 26th Annual Needham Growth Conference (PR Newswire)
Jan-03-24 04:05PM	Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Nov-21-23 04:05PM	Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-23 01:06PM	Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.89%
Nov-13-23 05:04PM	Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure (GuruFocus.com)
04:07PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023 (PR Newswire)
04:06PM	Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation (PR Newswire)
04:05PM	Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project (PR Newswire)
Nov-10-23 04:05PM	Azenta to Participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-23 04:05PM	Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-19-23 04:05PM	Azenta to Host GENEWIZ Week November 6-10, 2023 (PR Newswire)
Sep-26-23 08:00AM	Azenta Announces CFO Transition (PR Newswire)
Sep-08-23 04:05PM	Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Sep-07-23 04:05PM	Azenta to Participate in the Baird 2023 Global Healthcare Conference (PR Newswire)
Aug-10-23 08:00AM	Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (PR Newswire)
Aug-09-23 04:05PM	Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference (PR Newswire) +20.33%
12:00PM	Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70% (Simply Wall St.)
Aug-08-23 04:05PM	Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 (PR Newswire)
Aug-03-23 04:05PM	Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jun-29-23 04:05PM	Azenta Announces New Biorepository in the Greater Boston Area (PR Newswire)
Jun-21-23 08:00PM	AZTA: Lowering target price to $36.00 (Argus Research)
May-31-23 10:24AM	Vazyme Signs Global Strategic Cooperation Agreement with Azenta (PR Newswire)
May-30-23 04:05PM	Azenta to Participate in the Jefferies Healthcare Conference (PR Newswire)
May-24-23 08:00AM	Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery (PR Newswire)
May-17-23 04:05PM	Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference (PR Newswire) +5.53%
May-09-23 04:05PM	Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment (PR Newswire) -18.89%
May-03-23 04:05PM	Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-26-23 08:00PM	AZTA: Lowering target price to $43.00 (Argus Research)
Apr-13-23 07:00PM	Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-15-23 05:06PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (PR Newswire)

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lin Lawrence Y.	EVP, CFO and Treasurer	Aug 11 '25	Buy	27.96	2,500	69,900	46,013	Aug 12 04:05 PM
Hughes Violetta	VP, Chief Accounting Officer	Feb 03 '25	Sale	52.97	317	16,791	9,603	Feb 04 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Jan 31 '25	Buy	45.88	417	19,132	27,916	Feb 04 04:10 PM
Pirogova Olga	SVP and CHRO	Nov 19 '24	Sale	40.07	548	21,958	19,373	Nov 21 04:10 PM
Hughes Violetta	VP, Chief Accounting Officer	Nov 19 '24	Sale	40.07	163	6,531	9,920	Nov 21 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Nov 19 '24	Sale	40.07	491	19,674	27,499	Nov 21 04:10 PM
Wang David Dong	SVP & GM, SMS	Nov 19 '24	Sale	40.07	348	13,944	24,114	Nov 21 04:10 PM
Joseph Jason	SVP, General Counsel, Secy.	Nov 19 '24	Sale	40.07	1,139	45,640	112,564	Nov 21 04:10 PM
Cueto Herman	EVP, Chief Financial Officer	Nov 19 '24	Sale	40.07	712	28,530	23,892	Nov 21 04:10 PM
Marotta John	President and CEO	Nov 18 '24	Buy	39.48	12,717	502,066	99,612	Nov 19 04:10 PM
Marotta John	President and CEO	Nov 19 '24	Buy	40.67	1,250	50,838	100,862	Nov 19 04:10 PM
Cornog William L	Director	Nov 18 '24	Buy	39.60	12,500	495,000	14,755	Nov 19 04:10 PM
HIRSCH DIDIER	Director	Nov 18 '24	Buy	39.50	1,000	39,500	3,465	Nov 19 04:10 PM
Madaus Martin D	Director	Nov 19 '24	Buy	40.77	4,940	201,404	7,405	Nov 19 04:00 PM
Cueto Herman	EVP, Chief Financial Officer	Oct 17 '24	Sale	43.68	1,595	69,670	24,604	Oct 21 04:10 PM

RGEN

Repligen Corp

HOLX

Hologic, Inc

AZTA

Azenta Inc

Upgrade your FINVIZ experience